Glioma & Astrocytoma in Adults

We have experience in treating the most complex types of gliomas and astrocytomas. Our nationally known team of neurosurgeons, neuro-oncologists, radiologists, radiation oncologists, and neuropathologists partners to create a customized treatment plan for you.

Your team of specialists uses sophisticated diagnostic techniques, such as advanced MRI and precision molecular diagnosis, which determines the tumor’s specific molecular makeup.

Treatment may include targeted drugs, immunotherapy, and treatments provided through cutting-edge clinical trials. We also offer Gamma Knife® radiosurgery, a targeted treatment that provides an alternative to surgery and radiation therapy. Ultimately, we personalize a care plan just for you.

Clinical Trials and Research Studies

Phase 3

ACNS1931: A Phase 3 Study of Selumetinib (NSC# 748727 IND# 77782) or Selumetinib in Combination with Vinblastine for non-NF1 non-TSC Patients with Recurrent or Progressive Low-Grade Gliomas (LGGs) Lacking BRAFV600E or IDH1 Mutations

Learn More

Phase 2

DAY101-001/PNOC026/FIREFLY-1: A Phase 2 Open-Label Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with BRAF-Altered Recurrent or Progressive Low-Grade Glioma

Learn More

Phase 6

GBM Agile Trial

Learn More

Phase 3

A Pivotal Randomized Open-Label Study of Optune (TTFields 200khz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

Learn More